Krane, Stephen

Losartan inhibits collagen I synthesis and improves the distribution and efficacy of nanotherapeutics in tumors

Diop-Frimpong, B., Chauhan, V. P., Krane, S., Boucher, Y., & Jain, R. K. (2011) · Proceedings of the National Academy of Sciences

Nanoparticle-Based Drug DeliveryCancer Cells and Metastasis

Cited by 733

Type III collagen is crucial for collagen I fibrillogenesis and for normal cardiovascular development

Liu, X., Wu, H., Byrne, M., Krane, S., & Jaenisch, R. (1997) · Proceedings of the National Academy of Sciences

Connective tissue disorders researchCollagen: Extraction and Characterization

Cited by 614

A Heritable Disorder of Connective Tissue: Hydroxylysine-Deficient Collagen Disease

Pinnell, S. R., Krane, S. M., Kenzora, J. E., & Glimcher, M. J. (1972) · New England Journal of Medicine

Connective tissue disorders researchDermatological and Skeletal Disorders

Cited by 414

Lysyl-Protocollagen Hydroxylase Deficiency in Fibroblasts from Siblings with Hydroxylysine-Deficient Collagen

Krane, S. M., Pinnell, S. R., & Erbe, R. W. (1972) · Proceedings of the National Academy of Sciences

Connective tissue disorders researchMetabolism and Genetic Disorders

Cited by 157

Expression of two human skeletal calcitonin receptor isoforms cloned from a giant cell tumor of bone. The first intracellular domain modulates ligand binding and signal transduction.

Gorn, A. H., Rudolph, S. M., Flannery, M. R., Morton, C. C., Weremowicz, S., Wang, T. Z., Krane, S. M., & Goldring, S. R. (1995) · Journal of Clinical Investigation

Receptor Mechanisms and SignalingParathyroid Disorders and Treatments

Cited by 100